SCHEMBL24036705

SCHEMBL24036705

COC(=O)C[C@H](NC(=O)CNC(=O)OC(C)(C)C)c1ccc(OC(F)F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.38
KMT2A Q03164 2/20 0.37
ATM Q13315 2/20 0.37
SLC6A9 P48067 2/20 0.36
SLC6A5 Q9Y345 2/20 0.36
PTPRB P23467 1/20 0.36
APLNR P35414 1/20 0.36
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
GPR139 Q6DWJ6 1/20 0.35
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
THRB P10828 1/20 0.34
EPHX2 P34913 2/20 0.34
PDE2A O00408 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
HTT P42858 1/20 0.33
ITGB1 P05556 1/20 0.33
ITGA4 P13612 1/20 0.33
HDAC3 O15379 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24036744 0.90 ITGB3 (0.40) PKMPTPRBAPLNRCTSSCTSK
SCHEMBL24036713 0.89 APLNR (0.36) PKMATMPTPRBAPLNRCTSS
SCHEMBL24036718 0.87 EGFR (0.35) KMT2ASLC6A9PTPRBAPLNRMEN1
SCHEMBL24036716 0.86 EGFR (0.35) ATMSLC6A9SLC6A5PTPRBAPLNR
SCHEMBL25624528 0.85 EPAS1 (0.35) KMT2APTPRBAPLNRGPR139MEN1
SCHEMBL24036817 0.85 ITGB3 (0.34) KMT2APTPRBAPLNRCTSSCTSK
SCHEMBL24036706 0.85 THRB (0.42) KMT2ASLC6A9PTPRBGPR139MEN1
SCHEMBL24341735 0.84 MEN1 (0.48) KMT2APTPRBCTSSCTSKMEN1
SCHEMBL24340797 0.84 MEN1 (0.48) KMT2APTPRBCTSSCTSKMEN1
SCHEMBL24036816 0.84 ITGB3 (0.35) PTPRBAPLNRGPR139THRBEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE UBE CORPORATION (JP) 2023-06-22 US disclosed
WO-2023085396-A1 PHARMACEUTICAL COMPOSITION FOR PROVIDING TREATMENT FOR OR PREVENTING ALPORT SYNDROME UBE株式会社 2023-05-19 WO disclosed
WO-2021230325-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE 宇部興産株式会社 2021-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE DHFR, DPYD, CYP2D6 PKM 3234/4885KMT2A 359/4885ATM 2803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.